Opko Health OPK Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Gross Profit by Business | ||||||
| Diagnostics | $16.04M+45.3% | $11.04M-25.6% | $14.84M-20.7% | $18.72M+2.1% | $18.33M-31.6% | |
| Pharmaceutical | $29.71M-43.9% | $52.99M+51.2% | $35.05M+14.2% | $30.68M+26.3% | $24.29M-58.0% | |
| Revenue by Product | ||||||
| Intellectual Property And Other | $14M— | —— | $18.7M+24.7% | $15M+22.0% | $12.3M— | |
| Rayaldee | $12.81M-24.1% | $16.87M+13.4% | $14.88M+2.4% | $14.53M+10.8% | $13.11M-34.0% | |
| Transfer Of Intellectual Property And Other | $13.97M-58.6% | $33.72M+79.9% | $18.75M+25.3% | $14.96M+22.0% | $12.27M-71.6% | |
| Revenue by Geography | ||||||
| CL | $14.87M-14.9% | $17.48M+21.7% | $14.36M-10.3% | $16M+10.1% | $14.53M-9.1% | |
| ES | $8.05M+11.4% | $7.22M+14.0% | $6.34M-5.8% | $6.72M+4.4% | $6.44M-5.4% | |
| IE | $9.68M-56.2% | $22.1M+83.0% | $12.08M+2.9% | $11.74M+114% | $5.48M-69.2% | |
| IL | $0-100% | $171K+22.1% | $140K+0.7% | $139K+90.4% | $73K-92.5% | |
| MX | $6.94M+10.9% | $6.26M-7.1% | $6.74M+7.0% | $6.3M+1.1% | $6.23M+18.7% | |
| Other Countries | $1.15M-1.1% | $1.17M+6.7% | $1.09M+7.5% | $1.02M+2.6% | $992K+6.3% | |
| US | $83.5M-11.2% | $94.05M-15.2% | $110.92M-3.4% | $114.88M-1.1% | $116.21M-14.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Opko Health break its business down?
- Opko Health (OPK) reports gross profit by business across 2 parts — Diagnostics and Pharmaceutical. Each is extracted from the segment footnotes and tracked over time.
- Where does Opko Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Opko Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
